Logo image of BREB.BR

BREDERODE (BREB.BR) Stock Fundamental Analysis

EBR:BREB - Euronext Brussels - LU1068091351 - Common Stock - Currency: EUR

106.6  -0.2 (-0.19%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BREB. BREB was compared to 102 industry peers in the Capital Markets industry. BREB has only an average score on both its financial health and profitability. BREB has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

BREB had positive earnings in the past year.
In the past year BREB had a positive cash flow from operations.
BREB had positive earnings in 4 of the past 5 years.
BREB had a positive operating cash flow in each of the past 5 years.
BREB.BR Yearly Net Income VS EBIT VS OCF VS FCFBREB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

1.2 Ratios

BREB's Return On Assets of 6.89% is amongst the best of the industry. BREB outperforms 85.29% of its industry peers.
BREB has a Return On Equity of 6.89%. This is comparable to the rest of the industry: BREB outperforms 58.82% of its industry peers.
With a decent Return On Invested Capital value of 5.17%, BREB is doing good in the industry, outperforming 74.51% of the companies in the same industry.
Industry RankSector Rank
ROA 6.89%
ROE 6.89%
ROIC 5.17%
ROA(3y)10.77%
ROA(5y)12.17%
ROE(3y)10.77%
ROE(5y)12.18%
ROIC(3y)N/A
ROIC(5y)N/A
BREB.BR Yearly ROA, ROE, ROICBREB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

1.3 Margins

BREB has a Profit Margin of 115.50%. This is amongst the best in the industry. BREB outperforms 98.04% of its industry peers.
BREB's Profit Margin has been stable in the last couple of years.
BREB has a Operating Margin of 115.50%. This is amongst the best in the industry. BREB outperforms 99.02% of its industry peers.
In the last couple of years the Operating Margin of BREB has remained more or less at the same level.
Industry RankSector Rank
OM 115.5%
PM (TTM) 115.5%
GM N/A
OM growth 3Y0.32%
OM growth 5Y-0.32%
PM growth 3Y0.31%
PM growth 5Y-0.32%
GM growth 3YN/A
GM growth 5YN/A
BREB.BR Yearly Profit, Operating, Gross MarginsBREB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80 100

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for BREB remains at a similar level compared to 1 year ago.
Compared to 5 years ago, BREB has about the same amount of shares outstanding.
BREB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BREB.BR Yearly Shares OutstandingBREB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
BREB.BR Yearly Total Debt VS Total AssetsBREB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

BREB has an Altman-Z score of 1770.00. This indicates that BREB is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BREB (1770.00) is better than 100.00% of its industry peers.
BREB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1770
ROIC/WACCN/A
WACCN/A
BREB.BR Yearly LT Debt VS Equity VS FCFBREB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

BREB has a Current Ratio of 0.24. This is a bad value and indicates that BREB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BREB (0.24) is comparable to the rest of the industry.
BREB has a Quick Ratio of 0.24. This is a bad value and indicates that BREB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.24, BREB is in line with its industry, outperforming 46.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.24
Quick Ratio 0.24
BREB.BR Yearly Current Assets VS Current LiabilitesBREB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.89% over the past year.
BREB shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.08% yearly.
The Revenue has grown by 72.57% in the past year. This is a very strong growth!
Measured over the past years, BREB shows a small growth in Revenue. The Revenue has been growing by 5.43% on average per year.
EPS 1Y (TTM)64.89%
EPS 3Y-3.76%
EPS 5Y5.08%
EPS Q2Q%21.15%
Revenue 1Y (TTM)72.57%
Revenue growth 3Y-4.05%
Revenue growth 5Y5.43%
Sales Q2Q%19.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BREB.BR Yearly Revenue VS EstimatesBREB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B
BREB.BR Yearly EPS VS EstimatesBREB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.46, the valuation of BREB can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of BREB indicates a somewhat cheap valuation: BREB is cheaper than 78.43% of the companies listed in the same industry.
BREB is valuated cheaply when we compare the Price/Earnings ratio to 28.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.46
Fwd PE N/A
BREB.BR Price Earnings VS Forward Price EarningsBREB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of BREB indicates a somewhat cheap valuation: BREB is cheaper than 69.61% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 85.16
EV/EBITDA N/A
BREB.BR Per share dataBREB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

BREB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.25
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.85%, BREB is not a good candidate for dividend investing.
BREB's Dividend Yield is comparable with the industry average which is at 6.20.
Compared to an average S&P500 Dividend Yield of 2.38, BREB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.85%

5.2 History

On average, the dividend of BREB grows each year by 7.49%, which is quite nice.
Dividend Growth(5Y)7.49%
Div Incr Years0
Div Non Decr Years0
BREB.BR Yearly Dividends per shareBREB.BR Yearly Dividends per shareYearly Dividends per share 2020 0.2 0.4 0.6 0.8 1

5.3 Sustainability

13.88% of the earnings are spent on dividend by BREB. This is a low number and sustainable payout ratio.
BREB's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP13.88%
EPS Next 2YN/A
EPS Next 3YN/A
BREB.BR Yearly Income VS Free CF VS DividendBREB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B
BREB.BR Dividend Payout.BREB.BR Dividend Payout, showing the Payout Ratio.BREB.BR Dividend Payout.PayoutRetained Earnings

More info and screens

BREDERODE

EBR:BREB (3/14/2025, 7:00:00 PM)

106.6

-0.2 (-0.19%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)03-20 2025-03-20
Inst Owners0.44%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.12B
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.85%
Yearly Dividend1.22
Dividend Growth(5Y)7.49%
DP13.88%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.46
Fwd PE N/A
P/S 13.25
P/FCF 85.16
P/OCF 85.16
P/B 0.79
P/tB 0.79
EV/EBITDA N/A
EPS(TTM)9.3
EY8.72%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.25
FCFY1.17%
OCF(TTM)1.25
OCFY1.17%
SpS8.05
BVpS134.8
TBVpS134.8
PEG (NY)N/A
PEG (5Y)2.25
Profitability
Industry RankSector Rank
ROA 6.89%
ROE 6.89%
ROCE 6.89%
ROIC 5.17%
ROICexc 5.17%
ROICexgc 5.17%
OM 115.5%
PM (TTM) 115.5%
GM N/A
FCFM 15.56%
ROA(3y)10.77%
ROA(5y)12.17%
ROE(3y)10.77%
ROE(5y)12.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-14.15%
ROICexcg growth 5Y-7.32%
ROICexc growth 3Y-14.15%
ROICexc growth 5Y-7.32%
OM growth 3Y0.32%
OM growth 5Y-0.32%
PM growth 3Y0.31%
PM growth 5Y-0.32%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 13.47%
Current Ratio 0.24
Quick Ratio 0.24
Altman-Z 1770
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.89%
EPS 3Y-3.76%
EPS 5Y5.08%
EPS Q2Q%21.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)72.57%
Revenue growth 3Y-4.05%
Revenue growth 5Y5.43%
Sales Q2Q%19.9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y64.87%
EBIT growth 3Y-3.74%
EBIT growth 5Y5.09%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.07%
FCF growth 3Y-4.65%
FCF growth 5Y-0.06%
OCF growth 1Y9.07%
OCF growth 3Y-4.65%
OCF growth 5Y-0.06%